Fierce Biotech

  1. Ionis and UCSD take an antisense approach to fighting treatment-resistant multiple myeloma arlene.weintraub Wed, 01/20/2021 - 09:32
  2. GSK, German Merck's $4.2B bintrafusp alfa drug a bust, fails to beat king Keytruda in lung cancer badams Wed, 01/20/2021 - 09:28
  3. Ride Health gives patients a lift to COVID-19 treatment, vaccine trials chale Wed, 01/20/2021 - 09:16
  4. Roller coaster ride for Verastem continues as 2 weeks into the job, its CMO quits badams Wed, 01/20/2021 - 09:03
  5. Adagene plans $125M IPO to go after cancer niches targeted by BMS and Pfizer ntaylor Wed, 01/20/2021 - 08:52